Peptidylglycine
Lu-amidating monooxygenase (PAM; EC 1.14.17.3) is a multifunctional protein containing two enzymes that act sequentially to catalyze the (Yamidation of neuroendocrine peptides. Peptidylglytine a-hydroxylating monooxygenase (PHM) catalyzes the first step of the reaction and is dependent on copper, ascorbate, and molecular oxygen. Peptidyl-cr-hydroxyglycine a-amidating lyase (PAL) catalyzes the second step of the reaction. Previous studies demonstrated that alternative splicing results in the production of bifunctional PAM proteins that are integral membrane or soluble proteins as well as soluble monofunctional PHM proteins. Rat PAM is encoded by a complex single copy gene that consists of 27 exons and encompasses more than 160 kilobases (kb) of genomic DNA. The 12 exons comprising PHM are distributed over at least 76 kb genomic DNA and range in size from 49-165 base pairs; four of the introns within the PHM domain are over 10 kb in length. Alternative splicing in the PHM region can result in a truncated, inactive PHM protein (rPAM-5), or a soluble, monofunctional PHM protein (rPAM-4) instead of a bifunctional protein. The eight exons comprising PAL are distributed over at least 19 kb genomic DNA. The exons encoding PAL range in size from 54-209 base pairs and have not been found to undergo alternative splicing. The PHM and PAL domains are separated by a single alternatively spliced exon surrounded by lengthy introns; inclusion of this exon results in the production of a form of PAM (rPAM-1) in which endoproteolytic cleavage at a paired basic site can separate the two catalytic domains.
The exon following the PAL domain en- 
INTRODUCTION
Many biologically active peptides are a-amidated at their COOH-terminus, a structural feature that is often essential for their biological activity. These peptides are produced from larger inactive precursors which are cleaved to form peptides having a glycine residue at their . Conversion of a peptidylglycine substrate into an a-amidated product is a twostep reaction involving the copper, ascorbate, and molecular oxygen-dependent production of a peptidyl-ahydroxyglycine intermediate; at physiological pH a second enzymatic activity catalyzes the subsequent formation of the a-amidated product (4-10). Both enzymes are derived from the bifunctional peptidylglycine a-amidating monooxygenase precursor (PAM; EC 1.14.17.3) (Fig. 1; Refs. 8, 11, 12) . PAM has broad substrate specificity and is found in many tissues. Amidation is often the rate-limiting step in peptide biosynthesis, and PAM expression is regulated in a tissuespecific fashion in response to endocrine manipulations (4). 1571 by on April 14, 2008 mend.endojournals.org Downloaded from MOL ENDO. 1992 ENDO. 1572 cDNA clones encoding 1 IO-kilodalton (kDa) bifunctional integral membrane protein forms of PAM have been isolated from bovine and rat pituitary, frog skin, rat heart atrium, and human and rat thyroid carcinoma cDNA libraries (13-l 9) . These PAM precursor proteins are predicted to contain an NH,-terminal signal sequence followed by a short propeptide.
The enzyme catalyzing the first step, peptidylglycine a-hydroxylating monooxygenase (PHM), constitutes the NH*-terminal third of the PAM precursor (Fig. 1) . The enzyme catalyzing the second step, peptidyl-cu-hydroxyglycine LYamidating lyase (PAL), constitutes the mid-region of the PAM precursor. The lyase domain is followed by a hydrophobic putative trans-membrane domain and a hydrophilic COOH-terminal putative cytosolic domain. Endoproteolytic digestion of this bifunctional integral membrane protein releases soluble PHM and PAL catalytic domains that are very resistant to further endoproteolytic degradation (22) . Several types of rat, bovine, and human PAM cDNA have been characterized; all appear to arise via alternative splicing (13-15, 17, 18, 20) (Fig. 1 ). Deletion of a 315nucleotide
(nt) segment (referred to as exon A) between the PHM and PAL domains distinguishes rat PAM-l (rPAM-1) from -2 and human PAM-A (hPAM-A) from -B (this segment is 321 nt in hPAM). Deletion of a 258-nt segment (exon B) containing the putative transmembrane domain generates a soluble, intragranular bifunctional PAM protein. Frog skin amidating enzyme-I and rPAM-4 encode soluble proteins that include only the monooxygenase domain; while rPAM-4 appears to arise via alternative splicing, amidating enzyme-l represents the product of a separate gene present in the tetraploid frog, Xenopus laevis (21). The various PAM proteins appear to differ in functionally significant ways. Expression of the individual forms of PAM cDNA in the neuroendocrine AtT-20 cell line indicates that the different PAM proteins exhibit distinct patterns of endoproteolytic processing and subcellular routing (23). In addition, the catalytic properties of PHM are altered upon limited endoproteolytic digestion of bifunctional PAM proteins (22) .
The nucleotide sequences of the known rat PAM cDNAs, as well as Southern blot analysis data, suggested that PAM was a single copy gene in the rat. As a first step toward understanding the mechanisms regulating PAM gene expression, we undertook elucidation of the structure of the gene encoding rat PAM. The genes encoding several multifunctional enzymes have been characterized; in general, they appear to have been constructed by assembling genes encoding the individual catalytic units (24) (25) (26) (27) (28) . In this report we describe the isolation and characterization of genomic clones containing the entire coding sequence of PAM, analysis of the exon/intron structure of the gene and localization of the gene for human PAM to the long arm of chromosome 5.
RESULTS
The Single Copy PAM Gene Preliminary Southern blot analysis using the bovine PAM (bPAM) cDNA probes shown in Fig. 1 that the gene encoding rPAM was complex. Further Southern blot analysis was carried out using different probes to determine whether the rat genome contains a single copy of the PAM gene (Fig. 2) . Since the 3'-untranslated region of many mRNAs occurs in a single large exon, a cDNA probe from the 3'-untranslated region of rPAM was used. A single restriction fragment was visualized by this probe for each enzyme, indicating that the rat genome contains a single copy of the PAM gene ( Fig. 2 ) (15). Subsequent analyses of Southern blots with several oligonucleotide probes contained within single exons confirmed this conclusion.
Primer extension analysis was carried out to determine the length of the 5'-untranslated region (Fig. 3) . A single major product of 167 nt was identified in atrium, hypothalamus, pituitary, and submaxillary gland; additional minor products were observed in anterior pituitary and submaxillary gland. The size of the major product suggests that rPAM transcripts in each of these tissues contain an additional 104 nt upstream of the nucleotides identified in rPAM-1 (17). The sequence reported for a PAM cDNA obtained from rat medullary thyroid carcinoma (19) includes 26 nt of sequence upstream of the sequence identified in rPAM-1.
Exon/lntron
Organization of the Rat PAM Gene
When this project was initiated, the only PAM cDNA probes available were those for bPAM; therefore, our rat genomic library was screened with three bPAM digested with the enzymes indicated was fractionated on an 0.8% agarose gel, transferred to Hybond N, immobilized, and visualized with a cDNA probe contained within the 3'-untranslated region of rat PAM. The &cl fragment (1.3 kb) visualized on the Southern blot is the 1.3 kb Sac1 fragment containing the most 3'-exon of the PAM gene.
cDNA probes spanning the sequence of bPAM (Fig. 1) . A set of eight partially overlapping phage containing PAM exons was identified in this way. A different amplified rat genomic library was subsequently screened in order to obtain phage containing the missing regions of the PAM gene. A set of five additional phage was identified by screening with oligonucleotide probes, screening with polymerase chain reaction (PCR) fragments spanning missing exons, and screening with riboprobes specific to the end of an insert abutting a gap. Upon analysis of these 13 phage, it was clear that phage containing at least three exons (exons 1, 7, and 17) were still missing. The existence and approximate size of exon 1 can be inferred from the length of the primer extension product and a comparison of the sequence contained in exon 2 and the most 5'-region of the published sequences for rPAM (17, 19) . Repeated screening of a rat genomic library with an oligonucleo- tide probe corresponding to the most 5'-region reported by Bertelson et al. (19) failed to identify phage containing the V-end of the PAM gene; use of the same sequence for PCR amplification across intron A was similarly unsuccessful.
Although assigned to a single exon in Table 1 , the 5'-end of the PAM gene may consist of more than one exon. Exon 7 was identified by PCR amplification across the intron separating exons 6 and 7. A similar approach failed to amplify a fragment between exons 1 and 2, exons 7 and 8, or exon 17 and either exon 16 or 18. Therefore a PCRbased methodology
[rapid amplification of genomic ends or (RAGE)] was developed in order to identify the genomic regions surrounding these exons. The physical map of the rPAM gene is shown in Fig.  4 , and sequences at exon/intron junctions are presented in Table 1 . The nucleotide sequences identified in all of the rPAM cDNAs ( Fig. 1 ) are contained in these 27 exons. The 27 exons are distributed across at least 160 kilobases (kb) of genomic DNA; gaps remain at six positions within introns, so the PAM gene may be substantially larger than this estimate. The three alternate 3'-untranslated regions identified in various PAM cDNAs are each contained within single exons (exon 13, the retained part of intron P immediately following exon 16 and exon 27) that are the largest in the PAM gene [1125, 1522, and 837 base pairs (bp), respectively].
The signal sequence and propeptide are included in exon 2. The monooxygenase domain is composed of 12 exons (exons 3-15, skipping exon 13) that are exclusively protein-coding and range in size from 49-185 bp, with an average size of 90 bp. The exons encoding PHM are distributed over at least 76 kb genomic DNA; since four of the remaining gaps in the PAM gene lie within introns in the PHM domain, this region may be substantially larger. The introns within the PHM domain range in size from 400 bp to over 20 Fig. 4 kb. While exons 8-l 3 are clustered within a 6-kb region, large introns separate many of the remaining individual exons or pairs of exons. The 315bp region separating the monooxygenase and lyase domains in rPAM-1 (referred to previously as optional exon A) is encoded by exon 16. The novel sequence that follows exon A in rPAM-4 represents a retained region of intron P (Fig. 1 ). Exon 16 is separated from the preceding final exon of the monooxygenase domain by an 11.6-kb intron and from the subsequent first exon of the lyase domain by intron P, which is over 23 kb in length.
The lyase domain is composed of eight exons (exons 17-24) ranging in size from 54-209 bp, with an average size of 125 bp. The exons encoding PAL are distributed over at least 19 kb genomic DNA, with the introns ranging in size from 230 bp to over 4.1 kb. With the genomic clones identified, a single gap remains within one intron in the lyase domain, which is more compact than the monooxygenase domain. Exon 25 encodes the Vans-membrane domain (formerly referred to as exon B,), and exon 26 encodes the 54-bp domain formerly referred to as exon B,, (14). The remainder of the COOH-terminal domain and the entire 3'-untranslated region are encoded by exon 27. The final three exons of the PAM gene span only 4 kb genomic DNA.
Comparison
of the Genes Encoding PAM and Dopamine ,B-Monooxygenase PHM and dopamine p-monooxygenase, a rate-limiting enzyme in catecholamine biosynthesis, both use copper, ascorbate, and molecular oxygen (4, 29). Analysis of their amino acid sequences revealed a structural similarity extending over 270 residues of PHM (30). Comparing hPHM (18) and human dopamine ,Gmonooxygenase, 29% of the amino acid residues were identical over this 30-kDa region. Further evidence for an evolutionary relationship of PHM and dopamine pmonooxygenase was sought by comparing the location of exon/intron junctions in the two genes (Fig. 5 ). Since the PAM gene has been characterized only in rat, the locations of exon/intron junctions in the human PAM gene were inferred by homology (18). The homologous region of PHM is encoded by 11 exons, whereas the homologous region of dopamine p-monooxygenase is encoded by eight exons (31). In four cases, two PHM exons appear to form a single dopamine p-monooxygenase exon; in one case, a single PHM exon appears to form two dopamine p-monooxygenase exons. lntron lengths are much shorter in dopamine p-monooxygenase than in PHM. Of the five exon/intron junctions that can be compared between PHM and dopamine p-monooxygenase, four were displaced by 2 bp or less. This conservation of exon/intron junctions lends further support to the existence of an evolutionary relationship between PHM and dopamine /I-monooxygenase, secretory granule-associated enzymes required for the production of neuropeptides and classical neurotransmitters.
Correlation of Exon/lntron Organization with Structural Features of the PAM Protein
The protein coding exons of the PAM gene are drawn to scale in Fig. 6 . The shape at the beginning and end of each exon indicates whether the exon/intron junction is type 0, type 1, or type 2; matching shapes can thus be spliced together without loss of reading frame. Exon 2, which includes much of the 5'-untranslated region, encodes the signal sequence and propeptide, terminating before the final nucleotide encoding the Lys-Arg sequence marking the end of the propeptide; the peptide encoded by exon 2 is not in the mature PHM protein. A maximum of 12 exons form the catalytic core of the PHM domain. Histidine-rich sequences thought to be involved in the interaction of the monooxygenase with copper are found in exons 5, 10, and 14. amino acids encoded by exon 15 comprise one of the A maximum of eight exons form the catalytic core of most species-specific regions of PAM; for example, the the lyase domain (Fig. 6) . The first exon of the lyase paired basic site in bovine PAM corresponds to the domain (exon 17) encodes the sequence -Arg-Gly-Aspsequence Lys383-Gln384 in rat PAM. Based on the sizes (RGD). For a number of extracellular matrix proteins, of the stable, catalytically active PHM proteins protheir RGD sequences are important in their interactions duced by digesting atrial membranes with exogenous with cell surface receptors of the integrin family (32, endoproteases, this region appears to be especially 33). Interestingly, an RGD sequence is found in three protease-sensitive (22). other enzymes involved in the posttranslational proc-essing of peptide hormones [furin and prohormone convertases 1 and 2 (PC1 and PC2)] (34-37). Exon 22 includes a potential N-glycosylation site and terminates immediately after the codons for a paired basic potential endoproteolytic cleavage site (Arg77g-Lys780). The remaining paired basic residues preceding the trans-membrane domain are included in exon 24.
The remaining exons encode protein domains that are not essential for either catalytic activity of PAM. Exon 16 encodes the single paired basic amino acid site situated between the PHM and PAL catalytic domains of rat PAM; in the bovine neurointermediate pituitary, endoproteolytic cleavage at this site separates PHM-A from PAL (38). Expression of rPAM-1 and -2 (Fig.1) in AtT-20 cells indicates that exon 16 must be present for the efficient separation of PHM from PAL (23). The species-specific segment of PAM encoded by exon 15 is not cleaved by the endogenous endoproteases to which PAM is exposed in AtT-20 cells.
The final three exons of the PAM gene may constitute a noncatalytic domain responsible for the routing of PAM proteins. Exons 25 and 26 correspond to the regions identified as optional exons B, and Bbr respectively, in our earlier analyses of forms of PAM mRNA (14). Exon 2.5 encodes the putative traans-membrane domain, terminating several amino acids after the ArgTrp-Lys-Lysag4 putative stop-transfer signal. Exon 26 is very species specific and includes an Arg-Lys sequence that would become available to intragranular endoproteases when expressed in the intragranular milieu. The remainder of the COOH-terminal domain is encoded by exon 27. Exon 27 includes two Arg-Lys sequences, several potential phosphorylation sites, a putative PEST sequence PEST score 20.8 using the PESTFIND program of Rogers et al. (39)], and the entire 3'-untranslated region. Studies on AtT-20 cells expressing PAM mRNAs truncated after the trans-membrane domain indicate that the presence of this COOHterminal domain is essential for retention of integral membrane forms of PAM in the perinuclear region (40).
Alternative
Splicing Generates Different Forms of PAM mRNA Each of the forms of Sprague Dawley rat PAM mRNA identified to date (Fig. 1) arises via alternative splicing (Fig. 7) . Despite the complexity of the PAM gene, alternative splicing has been found to occur at only a few sites. Although primer extension studies (Fig. 3) identified a single major product in several tissues, further investigation will be required to determine whether alternative splicing occurs within the 5'-untranslated region of the PAM gene. Within the PHM domain, the only product of alternative splicing identified is rPAM-5, an apparently nonfunctional derivative of PHM (14). In rPAM-5, exon 13 encodes five amino acids before reaching a stop codon and includes an AT-rich region with four potential poly(A) addition signals; the only rPAM-5 cDNA isolated did not include a poly(A) tail.
Exon 16 encodes the 315 bp optional exon A and is followed immediately by the unique sequence of rPAM-4. Generation of monofunctional rPAM-4 mRNA thus appears to involve retention of the 5'-end of intron P and use of an alternative poly(A) addition signal. Generation of rPAM-1 mRNA requires use of a cryptic 5'-splice donor site included in the protein-coding sequence of rPAM-4. PAM mRNAs lacking exon A (rPAM-2, -3, -3a, and -3b) are produced when exon 15 is spliced to exon 17, skipping exon 16 entirely. rPAM-4 mRNA is found only in tissues where rPAM-1 is prevalent (atrium and central nervous system) and is not a major form of PAM mRNA in any of the tissues examined (20).
Exons 25 and 26 form a group of cassette exons; since the exon boundaries on both sides of these two exons are type 1, they can be spliced together in any combination and maintain the reading frame. The functional consequences of deleting exon 25 are obviously profound, with an integral membrane protein (e.g. rPAM-1, -2, and -3b) converted into a soluble, intragranular protein (rPAM-3a or -3). Splicing in this region is also tissue specific (20).
In general the sequences flanking the exon/intron junctions of the rPAM gene (Table 1) are very similar to the exon/intron junction sequences tabulated for mammalian genes by Shapiro and Senepathy (41). Examination of the subset of exon/intron junctions that are subject to alternative splicing reveals some differences. lntron Y, which follows exon 25 (BJ (Fig. 7) contains a highly unusual AGgcaagt sequence; of the 1893 5'-splice sites examined by Shapiro and Senepathy (41) only five lacked a gt sequence, and all contained instead a gc sequence. Included in this small group is human superoxide dismutase, another copper-dependent enzyme. Although less than 2% of the 3'-splice sites examined by Shapiro and Senepathy (41) contained an ag within IO bases upstream of the true 3'-splice site, intron Y terminates agcagAT. When compared to rPAM-1 or -2, the type B rat PAM cDNA (Fig. 1) isolated from medullary thyroid carcinoma contains an extra Ala residue at the junction of exons 25 and 26, suggesting that under some circumstances the upstream ag serves as the 3'-end of intron Y. A similar situation may occur at the 3'-end of intron X, between exons 24 and 25 (B,). The type B rat PAM cDNA isolated from medullary thyroid carcinoma lacks a Glu at the junction of exons 24 and 25; inclusion of this triplet (gaa) in intron X would place an ag sequence in exactly the same position observed in intron Y.
Chromosomal
Localization of hPAM Gene
Two human somatic cell hybrid panels were used to determine on which human chromosome the PAM gene is located (Fig. 8) . Species-specific pairs of sense and antisense oligonucleotides situated within the most 3'-exon of the PAM gene were designed and used to determine which somatic cell hybrids contained the hPAM gene. The primers specific for rPAM efficiently amplify a fragment of the same size (294 bp) from mouse genomic DNA (not shown) but fail to amplify a (Fig. 8) . Analysis of two somatic cell hybrid panels indicated 0% discordancy of the PAM gene with chromosome 5 (Table 2) . Since the BIOS Corporation panel (Fig. 86) contains cells with partial deletions of chromosome 5, it was possible to localize the PAM gene to the long arm of chromosome 5 (5q). The gene for human PC1 , a subtilisin-like endoprotease involved in prohormone processing, is also situated on the long arm of chromosome 5 (42).
DISCUSSION
A single complex gene encodes the two enzymes that must act sequentially to bring about the cu-amidation of peptides in endocrine tissues, the nervous system, the gastrointestinal system, and other tissues producing LYamidated peptides. The 27 exons that account for all of the PAM cDNAs characterized to date are distributed over more than 160 kb genomic DNA. The two catalytic domains (PHM and PAL) account for much of the multifunctional PAM protein. The PHM domain encompasses a maximum of 12 exons; the PAL domain encompasses a maximum of eight exons. As observed for other multifunctional enzymes, expression of truncated cDNAs encoding a single catalytic domain leads to the production of active enzyme; thus synthesis of the bifunctional PAM protein is not required for proper folding (23; see Ref. 45 ). The protein-coding exons average 106 bp in length, typical of vertebrate exons, but the internal introns, ranging from 200 to over 20,000 bp in length, are much longer than typically seen in vertebrate genes (43, 44) .
A single difference (nt 1212 in exon 12) was noted when comparing our previous cDNA sequences to the genomic sequence; His305 was encoded by CAC in the genomic sequence and by CAT in all of the PAM cDNAs characterized previously in this laboratory (14, 17, 20) . A CAC codon was observed at the corresponding position in PAM cDNAs derived from Wistar rat pituitary (15), and both sequences were observed in the PAM and PC1 within the same region on the long arm of chromosome 5 (42). Colocalization of the genes encoding PC1 and PAM to the long arm of chromosome 5 may be of functional significance. The genes encoding PC2 and furin are located on human chromosomes 20 and 15, respectively (42). Gene structures have been elucidated for only a few of these enzymes, and PAM is one of the most complex. The gene encoding human furin encompasses only 5.4 kb genomic DNA and consists of eight exons (45). The gene encoding rCPE encompasses 50 kb genomic DNA and consists of nine protein-coding exons; the smallest exon contains 100 bp, and introns range in size from 1.6-12.5 kb (46); alternative splicing is not used as a mechanism of generating diversity in CPE. The gene encoding human angiotensin-converting enzyme is also complex, comprising 26 exons spanning 21 kb; tissuespecific use of two alternate promoters generates two angiotensin-converting enzyme mRNAs (47). Significant regions of the PHM domain and dopamine P-monooxygenase are clearly related in evolution. In addition to the 29% amino acid sequence identity between hPHM and dopamine p-monooxygenase over the region pointed out by Southan and Kruse (30), we show here that many of the exon/intron junctions in the homologous region are conserved (Fig. 7) . PAM and dopamine P-monooxygenase may have evolved from an ancestral gene composed of more exons than either current gene, with different introns lost in the evolution CPA and CPB is only 17-21%, and the location of only one exon/intron junction is conserved (46).
As observed for many other genes (48), alternative splicing is used to create functional diversity from the single copy PAM gene. Two sites within the PAM gene account for most of the alternatively spliced forms of PAM mRNA. Alternative splicing determines whether PAM proteins will be integral membrane proteins or soluble proteins and whether the two catalytic domains will be separated from each other by endogenous endoproteases cleaving at a paired basic amino acid site (Fig. 7) . Exon 16 is present in PAM RNAs in heart and central nervous system but is commonly spliced out of PAM mRNAs in pituitary or submaxillary gland (20). The presence of exon A in a bifunctional PAM protein requires the use of a cryptic 5'-splice site within the protein-coding region of the sequence specific to rPAM-4 and not the retention of an unspliced intron as postulated by Bertelson et a/. (19). The presence or absence of the exon encoding the trans-membrane domain (exon 25) determines whether the COOH-terminus of PAM will be exposed to the cytosol or sequestered within the lumen of the secretory pathway.
Three alternate 3'-untranslated regions have been identified in the PAM gene (exon 13, the retained part of intron P, and exon 27); all contain consensus poly(A) addition signals (Table 1 ) (50) although the presence of a poly(A) tail in rPAM-5 mRNAs has not been documented. Use of alternate poly(A) addition sites determines whether monofunctional rPAM-4 or nonfunctional rPAM-5 protein will be made; neither rPAM-4 nor rPAM-5 is a major transcript in any of the tissues examined. Although the utility of producing rPAM-5 is unclear, expression of an inactive form of glutamic acid decarboxylase, which is also governed by alternative splicing, is closely regulated during development (51).
The interdomain regions of the multifunctional proteins that have been characterized tolerate higher rates of mutation than the catalytic domains and are sites at which exogenous endoproteases can cleave to release active catalytic domains (28, 52). Comparison of the sequences of frog, bovine, rat, and human PAM identified exon 15, the part of exon 25 preceding the transmembrane domain and exon 26 as poorly conserved regions (4). The sizes of the active PHM and PAL fragments generated by limited endoproteolytic digestion of atrial membranes are consistent with the identification of exons 15 and 25 as protease-sensitive interdomain regions (22). The fact that exon 27 is highly conserved suggests that it is functionally important.
When precautions are taken to prevent endoproteolytic degradation during purification, most of the multifunctional proteins that have been studied [e.g. CAD, arom, and fatty acid synthase (FAS)] are isolated as intact polypeptides containing all of the catalytic domains (24,26,28) .
In contrast, endoproteolytic cleavage of PAM into its component parts occurs in a tissuespecific fashion and may be governed in part by the presence or absence of exon 16 (optional exon A). Expression of rPAM-1 and rPAM-2 in AtT-20 cells indicates that the presence of this region is essential if the resident enzymes are to separate the PHM and PAL catalytic domains by endoproteolytic cleavage (23). Exon 16, while clearly not essential for expression of either catalytic activity, is highly conserved and thus not typical of an interdomain region and may serve as a domain permitting controlled endoproteolytic processing.
Expression of exons 25-27 is not required for production of catalytic activity, and these three exons may function as a routing domain. PAM transcripts that include exon 25 (rPAM-1, -2, and -3b) have a transmembrane domain and are integral membrane proteins. Expression of mutant forms of PAM-l truncated immediately after the trans-membrane domain and lacking all of the peptide encoded by exons 26 and 27 indicates that this part of the protein plays a role in the proper routing of the protein in .
Multifunctional enzymes are especially common in the biosynthetic pathways of lower eukaryotes, where they catalyze two or more consecutive reactions (52). The pentafunctional arom proteins of fungi and yeast, which catalyze steps two to six in prechorismate polyaromatic amino acid biosynthesis, are thought to have arisen by fusion of individual ancestral genes (26, 52). The trifunctional CAD protein, which catalyzes the first three steps in mammalian de nova pyrimidine biosynthesis (53), and the multifunctional FAS protein, which catalyzes all of the steps from acetyl-coenzyme A and malonyl-coenzyme A to palmitate (28, 54) are also thought to have arisen by fusion of ancestral genes. The expression of PAM, like the expression of many of these other multifunctional enzymes, is tissue specific and developmentally and hormonally regulated. Despite the complexity of the PAM gene, transcription appears to be initiated at the same start site in several different tissues. By linking expression of PHM and PAL in the bifunctional PAM protein, coordinate regulation is ensured. It will be of great interest to elucidate the structure of the two amidating enzyme genes in Xenopus laevis. Further investigations will focus on the 5'-flanking region of the PAM gene and identification of the sequences responsible for regulation of its expression. l789-2034) probe, no positive phage could be identified.
MATERIALS AND METHODS

Construction
The commercial librarv (600,000 pfu) was also screened using an end-labeled ojigonucleotidk probe corresponding to rPAM(523-553) and yielded phage G2. In order to close the gaps between nonoverlapping phage, riboprobes were prepared from the ends of genomic inserts adjacent to gaps. Phage DNA from G13 and G19 was cleaved with Rsal, and riboprobes were synthesized using the appropriate polymerase and L~-[~*P]CTP (800 &i/mmol).
These riboprobes were used to screen 500,000 pfu from the commercial library; phage G13a (G13 3'-riboprobe) and G19a (G19 5'-riboprobe) were identified in this manner. Riboprobes prepared from G2 and G3 failed to identify additional sequences in the PAM gene. The 13 partially overlapping genomic clones span a total of approximately 160 kb genomic DNA, leaving six gaps (Fig. 4) were generally as follows: denaturation at 94 C for 1 min, annealing at 50 C for 1 min, extension at 70 or 72 C for 2-4 min; the last extension time was lengthened to 10 min. Amplified DNA fragments were analyzed on agarose gels and visualized with ethidium bromide.
Identification of Exons Not Found in Genomic Clones
Exons 7 and 17 were not contained within any of the genomic phage identified.
Exon 7 was subsequently identified by amplification of genomic DNA with an antisense primer contained within exon 7 and a sense primer contained within exon 6. The amplified fragment was subcloned, and the exon/intron junctions were sequenced. Exon 17 was not recovered in any of the 13 genomic clones, and PCR amplification from either exon 16 or exon 18 into exon 17 failed to yield a product. Therefore, the methodology developed to extend cDNA sequences [rapid amplification of cDNA ends (RACE)] (59) was modified for use in identifying introns surrounding a known exon (biotin-RAGE) (60). The introns preceding and following exon 17 and the intron following exon 7 were identified in this way.
In brief, rat liver genomic DNA was cut with a restriction enzyme recognizing a four-bp sequence not present in the exon of interest (in this case, Mbol). A poly(A) tail was added to the cut genomic DNA using terminal deoxynucleotidyl transferase as described in the RACE protocol (59). Amplification was then carried out using an exon-specific primer and the RAGE-hybrid primer, which consists of three consecutive restriction sites (EcoRI, Sacl. and BsolO6) followed bv an oligo(dT) tail (5'-GAAiTCGAGCTCATCGAT,,-3'). Souihern blot analysis was performed on an aliquot of the amplified DNA to test for the presence of sequences homologous to the exon in question.
An aliquot of this reaction mix was aqain amplified using a biotinyjated cDNA-specific primer and-the RAGE-hvbrid primer. The oroducts of the second PCR reaction were bound to streptavidin-linked magnetic beads (Dynal Inc., Great Neck, NY), and nonbiotinylated contaminants were washed away. DNA bound to the magnetic beads was again subjected to PCR amplification using the same biotinylated ' Sequence data across all exon/intron junctions have been submitted to GenBank, accession numbers LO1 668-L01693.
primer (or a nested, exon-specific primer) and the RAGE hybrid primer. The products of this second PCR amplification were fractionated by agarose gel electrophoresis, excised from the gel, subcloned, and sequenced.
To control for errors introduced by PCR, at least two subcloned fragments were sequenced.
In addition, intronic primers flanking exon 17 were used to amplify a genomic fragment including exon 17; the sequence of this subcloned fragment was identical to those obtained using the RAGE-hybrid primer (60).
Primer Extension Analysis
Total RNA was prepared from adult rat tissues using the acid guanidinium isothiocyanate-phenol-chloroform procedure (61). Poly(A)+ RNA was purified by oligo(dT)-cellulose affinity chromatography.
An 
Chromosomal Localization
Pairs of sense and antisense oligonucleotide primers capable of distinguishing rodent from human PAM were used to determine which members of two separate hybrid cell panels contained the gene for hPAM (62). The primer pairs were selected from within the lengthy exon containing the COOH-terminal end of the PAM protein and the 3'-untranslated region; since cDNAs for mouse and Chinese hamster PAM have not been characterized, primers were selected based on the sequence of rPAM and tested for species specificity.
Both primers of the pair specific to rPAM and (3418-3402)] differ from the corresponding region of hPAM (18) at four of 17 sites.
Both primers of the pair specific to hPAM [hPAM(2944 [hPAM( -2963 and (3349-33291 differ from the corresponding region of rPAM and (3467-3447)] at five sites. The primer pairs are species specific when used to amplify 100 ng genomic DNA or 10 pg plasmid DNA; with larger amounts (10 ng) of human plasmid DNA, the rat PAM primer pair amplifies the hPAM plasmid. 
